Becker's Payer Issues | Payer News

Molecular residual disease (MRD) testing is moving into the next phase of precision oncology, extending molecular insight past diagnosis and treatment selection into post-treatment monitoring, surveillance and survivorship. For health systems, the question is not whether to add another test.…

Many healthcare organizations are exploring AI, but moving from experimentation to meaningful operational impact remains a challenge. Join Omkar Kulkarni, Vice President and Chief Innovation & Transformation Officer, and Amani Zaki, Manager of Language and Cultural Services at Children’s Hospital…

Eligibility churn and redetermination pressure remain significant for revenue cycle teams, but they’re no longer the whole story. Heading into 2027, new Medicaid community engagement and six-month renewal requirements will add eligibility complexity for affected populations, while Medicare payment updates…

Rural and underserved hospitals nationwide face a growing challenge: widening gaps in specialty care. A Becker’s Healthcare survey of 100 hospital and health system leaders across roughly 30 states suggests the primary issue isn’t technology — it’s a shortage of…

Every patient recovering in an inpatient bed who could safely recover at home is a patient in the wrong setting. Meanwhile, a patient in need of acute care waits for a bed. Arlington, Va.-based VHC Health addressed this challenge by…

By the time MLR pressure shows up in your numbers, the margin may already be locked into the quarter. The question is whether you’ll spot the signals early enough to change the outcome. Most health plans don’t recognize margin pressure…